194.42

0.33% -0.64

After Hours: 195.10 0.68 +0.35%

Accenture Plc (ACN)

Overview News Price History Option Chain Financials Why ACN Down? Discussions Forecast Dividend History

Accenture Plc stock is traded at $194.42, with a volume of 4.20M. It is down -0.33% in the last 24 hours and down -2.79% over the past month. Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount, with around 800,000 employees in over 120 countries.

Previous Close:

$195.06

Open:

$195.15

24h Volume:

4.20M

Relative Volume:

0.63

Market Cap:

$119.36B

Revenue:

$72.11B

Net Income/Loss:

$7.80B

P/E Ratio:

15.93

EPS:

12.2075

Net Cash Flow:

$12.50B

1W Performance:

+2.13%

1M Performance:

-2.79%

6M Performance:

-22.39%

1Y Performance:

-30.37%

1-Day Range:

$193.78

$199.53

1-Week Range:

$191.29

$199.65

52-Week Range:

$177.50

$325.71

Accenture Plc Stock (ACN) Company Profile

Name

Accenture Plc

Sector

Technology (772)

Industry

Information Technology Services (72)

Phone

353-1-646-2000

Address

1 GRAND CANAL SQUARE, DUBLIN

Employee

779,000

Twitter

@Accenture

Next Earnings Date

2026-03-19

Latest SEC Filings

ACN's Discussions on Twitter

Compare ACN vs IBM, INFY, FISV, CTSH

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACN Accenture Plc	194.42	119.75B	72.11B	7.80B	12.50B	12.21
IBM International Business Machines Corp	255.68	238.08B	67.54B	10.57B	11.46B	11.15
INFY Infosys Ltd Adr	14.07	57.50B	19.87B	3.21B	3.89B	0.7748
FISV Fiserv Inc	63.26	34.19B	21.19B	3.49B	4.34B	6.3353
CTSH Cognizant Technology Solutions Corp	60.45	28.82B	21.11B	2.23B	2.60B	4.5574

Accenture Plc Stock (ACN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-20-26	Upgrade	HSBC Securities	Reduce → Hold
Feb-17-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-22-26	Initiated	Berenberg	Buy
Jan-06-26	Initiated	Truist	Buy
Dec-16-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-23-25	Initiated	Citigroup	Neutral
Oct-22-25	Initiated	Wells Fargo	Equal Weight
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral
Jul-28-25	Initiated	HSBC Securities	Reduce
Jul-17-25	Resumed	Deutsche Bank	Hold
Jul-17-25	Initiated	Evercore ISI	Outperform
Mar-17-25	Upgrade	Robert W. Baird	Neutral → Outperform
Jan-08-25	Upgrade	Wolfe Research	Peer Perform → Outperform
Dec-06-24	Upgrade	Goldman	Neutral → Buy
Oct-30-24	Downgrade	Exane BNP Paribas	Outperform → Neutral
Sep-30-24	Upgrade	TD Cowen	Hold → Buy
Sep-26-24	Upgrade	Piper Sandler	Neutral → Overweight
Jul-19-24	Upgrade	UBS	Neutral → Buy
Jun-26-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-24-24	Initiated	Goldman	Neutral
May-15-24	Downgrade	Deutsche Bank	Buy → Hold
Mar-21-24	Downgrade	Susquehanna	Positive → Neutral
Mar-19-24	Initiated	Guggenheim	Buy
Jan-30-24	Initiated	Mizuho	Buy
Jan-17-24	Upgrade	Exane BNP Paribas	Neutral → Outperform
Nov-16-23	Initiated	Redburn Atlantic	Buy
Nov-07-23	Initiated	UBS	Neutral
Jun-23-23	Downgrade	TD Cowen	Outperform → Market Perform
Jun-15-23	Upgrade	Piper Sandler	Underweight → Neutral
Apr-05-23	Upgrade	Edward Jones	Hold → Buy
Jan-30-23	Initiated	Wells Fargo	Equal Weight
Dec-12-22	Downgrade	Piper Sandler	Neutral → Underweight
Jun-29-22	Downgrade	Exane BNP Paribas	Outperform → Neutral
Jan-10-22	Initiated	Goldman	Neutral
Dec-17-21	Reiterated	BMO Capital Markets	Market Perform
Dec-17-21	Reiterated	Citigroup	Buy
Dec-17-21	Reiterated	Deutsche Bank	Buy
Dec-17-21	Reiterated	UBS	Neutral
Dec-17-21	Reiterated	Wolfe Research	Peer Perform
Sep-22-21	Upgrade	MoffettNathanson	Neutral → Buy
Jul-26-21	Upgrade	Redburn	Neutral → Buy
Jun-23-21	Upgrade	Exane BNP Paribas	Neutral → Outperform
Jun-21-21	Initiated	Jefferies	Hold
Mar-18-21	Upgrade	BofA Securities	Neutral → Buy
Mar-08-21	Upgrade	Susquehanna	Neutral → Positive
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral
Dec-18-20	Resumed	Wells Fargo	Equal Weight
Dec-07-20	Downgrade	Susquehanna	Positive → Neutral
Nov-19-20	Initiated	Goldman	Buy
Sep-23-20	Resumed	UBS	Neutral
Sep-22-20	Reiterated	Wedbush	Outperform
Jun-18-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-03-20	Downgrade	Exane BNP Paribas	Outperform → Neutral
May-22-20	Initiated	Piper Sandler	Neutral
Apr-15-20	Initiated	Exane BNP Paribas	Outperform
Mar-20-20	Upgrade	MoffettNathanson	Neutral → Buy
Mar-10-20	Upgrade	Societe Generale	Hold → Buy
Feb-19-20	Initiated	Atlantic Equities	Overweight
Jan-21-20	Initiated	Berenberg	Buy
Jan-07-20	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-07-20	Downgrade	MoffettNathanson	Buy → Neutral
Jan-06-20	Upgrade	Wolfe Research	Underperform → Peer Perform
Dec-26-19	Reiterated	Argus	Buy
Dec-23-19	Reiterated	Cowen	Outperform
Sep-20-19	Initiated	Barclays	Overweight
May-03-19	Downgrade	BofA/Merrill	Buy → Neutral

View All

Accenture Plc Stock (ACN) Latest News

Apr 21, 2026

Accenture (ACN) Partners with WaveMaker for App Modernization - GuruFocus

Apr 21, 2026

What The AI-Transition Really Means For IT Services, And Why Accenture Seems All Set To Dominate - Seeking Alpha

Apr 21, 2026

Accenture price shows more negative signsForecast today21-03-2026 - Economies.com

Apr 21, 2026

Piraeus partners Accenture and Anthropic to launch new AI hub - FinTech Futures

Apr 21, 2026

OpenAI working with consulting firms, including Accenture, Capgemini and PwC, to help sell Codex to businessesWSJ - marketscreener.com

Apr 21, 2026

Accenture and Avanade partner with Microsoft on agentic factory solution - verdict.co.uk

Apr 21, 2026

Apr 20, 2026

Accenture PLC Cl A stock underperforms Monday when compared to competitors - MarketWatch

Apr 20, 2026

Piraeus and Accenture Team Up to Launch ΑΙ Hub in the Greek Banking Sector Powered by Anthropic - 01net

Apr 20, 2026

Accenture, Piraeus Bank Team Up for Greek AI Hub Built on Anthropic's Tech - marketscreener.com

Apr 20, 2026

$29.6+ BN Life Sciences Consulting Services Market Forecasts to 2034: Rising Drug Complexity, AI & Big Data Adoption, Demand for Real-World Evidence, and Biotech Expansion with Novel Therapies - GlobeNewswire Inc.

Apr 20, 2026

Accenture's New Agentic Factory System Debuts With Microsoft - Benzinga

Apr 20, 2026